People also experienced improvements in their fasting glucose, A1C, blood pressure, waist circumference, and normal levels of insulin while taking tirzepatide
Tirzepatide is a once-weekly subcutaneous injection administered in the abdomen, thigh, or upper arm
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
The addition of metabolic support further enhances how the body processes and utilizes energy
aka glucose-dependent insulinotropic peptide) was infused into humans IV, insulin immunoreactivity increased and glucose tolerance was improved (54)
A., Matveyenko, A., Kassem, M., Andersen, T